Table 5.
Mean Change from Baseline in Vital Signs During Tadalafil Treatment
Observation Period | n | Mean | 95% CI |
---|---|---|---|
Systolic Blood Pressure (mmHg) | |||
1M | 481 | −3.2 | −4.4 to –2.0 |
2M | 325 | −2.8 | −4.3 to –1.3 |
3M | 419 | −2.0 | −3.4 to –0.5 |
6M | 396 | −1.3 | −2.8 to 0.2 |
9M | 297 | −4.2 | −6.0 to –2.5 |
12M | 337 | −3.5 | −5.2 to –1.8 |
18M | 310 | −1.9 | −3.7 to 0.0 |
LOCF | 587 | −2.1 | −3.4 to –0.8 |
Diastolic Blood Pressure (mmHg) | |||
1M | 481 | −2.5 | −3.3 to –1.6 |
2M | 325 | −2.9 | −3.9 to –1.8 |
3M | 419 | −2.7 | −3.7 to –1.7 |
6M | 395 | −2.5 | −3.5 to –1.4 |
9M | 297 | −3.9 | −5.1 to –2.8 |
12M | 337 | −3.4 | −4.4 to –2.3 |
18M | 310 | −2.8 | −4.0 to –1.6 |
LOCF | 586 | −2.8 | −3.6 to –1.9 |
Abbreviations: CI, confidence interval; LOCF, last observation carried forward; M, month(s); n, number of patients analyzed.